Average Co-Inventor Count = 5.60
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Nerviano Medical Sciences S.r.l. (20 from 138 patents)
2. Pfizer Italia S.r.l. (9 from 23 patents)
3. Pharmacia & Upjohn (4 from 117 patents)
4. Farmitalia Carlo Erba S.r.l. (1 from 140 patents)
5. Blaschim S.p.a. (1 from 12 patents)
6. Congenia Slr (1 from 1 patent)
7. Cogenia Srl (1 from 1 patent)
8. Pharmacia Italia S.p.a. (26 patents)
9. Congenia S.r.l. (1 patent)
37 patents:
1. 10280176 - Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
2. 9637497 - Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
3. 9464090 - Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
4. 9012487 - Bicyclo-pyrazoles active as kinase inhibitors
5. 8981089 - Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
6. 8785448 - Substituted pyrrolo-pyrazole derivatives as kinase inhibitors
7. 8669261 - Acrylomido derivatives useful as inhibitors of the mitochondrial permeability transition
8. 8557857 - Substituted pyrrolo-pyrazole derivatives as kinase inhibitors
9. 8557845 - Substituted pyrrolo-pyrazole derivatives as kinase inhibitors
10. 8541429 - Pyrazolo quinazoline derivatives, process for their preparation and their use as kinase inhibitors
11. 8481584 - 1H-thieno[2,3-c]pyrazole derivatives useful as kinase inhibitors
12. 8481585 - Substituted pyrrolo-pyrazole derivatives as kinase inhibitors
13. 8470831 - Acrylamido derivatives useful as inhibitors of the mitochondrial permeability transition
14. 8461193 - Substituted pyrrolo-pyrazole derivatives active as kinase inhibitors
15. 8273765 - Bicyclo-pyrazoles and pharmaceutical compositions comprising them